124 related articles for article (PubMed ID: 31988322)
1. Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors.
Song P; Zhang J; Shang C; Zhang L
Sci Rep; 2020 Jan; 10(1):1525. PubMed ID: 31988322
[TBL] [Abstract][Full Text] [Related]
2. Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer.
Ahn S; Lee JC; Shin DW; Kim J; Hwang JH
Sci Rep; 2020 Dec; 10(1):21552. PubMed ID: 33273671
[TBL] [Abstract][Full Text] [Related]
3. Author Correction: Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination.
Gilad Y; Eliaz Y; Yu Y; Han SJ; O'Malley BW; Lonard DM
Sci Rep; 2020 Mar; 10(1):4463. PubMed ID: 32132607
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.
Hou J; Zhao R; Xia W; Chang CW; You Y; Hsu JM; Nie L; Chen Y; Wang YC; Liu C; Wang WJ; Wu Y; Ke B; Hsu JL; Huang K; Ye Z; Yang Y; Xia X; Li Y; Li CW; Shao B; Tainer JA; Hung MC
Nat Cell Biol; 2020 Nov; 22(11):1396. PubMed ID: 33033376
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1.
Yu J; Qin B; Moyer AM; Nowsheen S; Tu X; Dong H; Boughey JC; Goetz MP; Weinshilboum R; Lou Z; Wang L
Cell Res; 2020 Sep; 30(9):823. PubMed ID: 32636455
[TBL] [Abstract][Full Text] [Related]
6. Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
Nature; 2019 Jul; 571(7766):E10. PubMed ID: 31270456
[TBL] [Abstract][Full Text] [Related]
7. Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort.
Su YY; Chiang NJ; Tsai HJ; Yen CJ; Shan YS; Chen LT
Sci Rep; 2020 Nov; 10(1):20199. PubMed ID: 33188263
[TBL] [Abstract][Full Text] [Related]
8. Author Correction: Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.
Epeldegui M; Conti DV; Guo Y; Cozen W; Penichet ML; Martínez-Maza O
Sci Rep; 2020 Jan; 10(1):748. PubMed ID: 31937870
[TBL] [Abstract][Full Text] [Related]
9. Author Correction: Improved ethanol electrooxidation performance by shortening Pd-Ni active site distance in Pd-Ni-P nanocatalysts.
Chen L; Lu L; Zhu H; Chen Y; Huang Y; Li Y; Wang L
Nat Commun; 2020 Mar; 11(1):1333. PubMed ID: 32152306
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.
Knox T; Sahakian E; Banik D; Hadley M; Palmer E; Noonepalle S; Kim J; Powers J; Gracia-Hernandez M; Oliveira V; Cheng F; Chen J; Barinka C; Pinilla-Ibarz J; Lee NH; Kozikowski A; Villagra A
Sci Rep; 2019 Oct; 9(1):14824. PubMed ID: 31597938
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer.
Pan B; Shen J; Cao J; Zhou Y; Shang L; Jin S; Cao S; Che D; Liu F; Yu Y
Sci Rep; 2020 May; 10(1):8808. PubMed ID: 32461548
[TBL] [Abstract][Full Text] [Related]
12. Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness.
Chen MJ; Wu DW; Wang YC; Chen CY; Lee H
Sci Rep; 2020 Oct; 10(1):18504. PubMed ID: 33097739
[TBL] [Abstract][Full Text] [Related]
13. Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer.
Li R; Ong SL; Tran LM; Jing Z; Liu B; Park SJ; Huang ZL; Walser TC; Heinrich EL; Lee G; Salehi-Rad R; Crosson WP; Pagano PC; Paul MK; Xu S; Herschman H; Krysan K; Dubinett S
Sci Rep; 2020 Mar; 10(1):4386. PubMed ID: 32127587
[TBL] [Abstract][Full Text] [Related]
14. Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Liu C; Yao Z; Wang J; Zhang W; Yang Y; Zhang Y; Qu X; Zhu Y; Zou J; Peng S; Zhao Y; Zhao S; He B; Mi Q; Liu X; Zhang X; Du Q
Cell Death Differ; 2020 Jul; 27(7):2293. PubMed ID: 32024980
[TBL] [Abstract][Full Text] [Related]
15. Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.
Färkkilä A; Gulhan DC; Casado J; Jacobson CA; Nguyen H; Kochupurakkal B; Maliga Z; Yapp C; Chen YA; Schapiro D; Zhou Y; Graham JR; Dezube BJ; Munster P; Santagata S; Garcia E; Rodig S; Lako A; Chowdhury D; Shapiro GI; Matulonis UA; Park PJ; Hautaniemi S; Sorger PK; Swisher EM; D'Andrea AD; Konstantinopoulos PA
Nat Commun; 2020 May; 11(1):2543. PubMed ID: 32424117
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolism.
Nishimura K; Murakami T; Sakurai T; Miyoshi M; Kurahashi K; Kishi S; Tamaki M; Tominaga T; Yoshida S; Nagai K; Abe H; Hui SP; Kotani K; Doi T
Sci Rep; 2019 Dec; 9(1):20270. PubMed ID: 31882578
[TBL] [Abstract][Full Text] [Related]
17. Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.
Wang YQ; Shen AJ; Sun JY; Wang X; Liu HC; Zhang MM; Chen DQ; Xiong B; Shen JK; Geng MY; Zheng M; Ding J
Acta Pharmacol Sin; 2020 May; 41(5):731-732. PubMed ID: 32081977
[TBL] [Abstract][Full Text] [Related]
18. Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1
Verma V; Shrimali RK; Ahmad S; Dai W; Wang H; Lu S; Nandre R; Gaur P; Lopez J; Sade-Feldman M; Yizhak K; Bjorgaard SL; Flaherty KT; Wargo JA; Boland GM; Sullivan RJ; Getz G; Hammond SA; Tan M; Qi J; Wong P; Merghoub T; Wolchok J; Hacohen N; Janik JE; Mkrtichyan M; Gupta S; Khleif SN
Nat Immunol; 2019 Nov; 20(11):1555. PubMed ID: 31551574
[TBL] [Abstract][Full Text] [Related]
19. Author Correction: Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population-Based Cohort Study.
Lee E; Han JH; Bang CH; Yoo SA; Han KD; Kim HN; Park YM; Lee JY; Lee JH
Sci Rep; 2020 Feb; 10(1):2284. PubMed ID: 32024918
[TBL] [Abstract][Full Text] [Related]
20. Author Correction: One-step Solution Processing of Ag, Au and Pd@MXene Hybrids for SERS.
Satheeshkumar E; Makaryan T; Melikyan A; Minassian H; Gogotsi Y; Yoshimura M
Sci Rep; 2020 Sep; 10(1):16069. PubMed ID: 32978494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
